Global Artificial Blood Substitutes Market to 2032
Overview
The Global Artificial Blood Substitutes Market is expected to reach a 76.05 USD Million by 2032 and is projected to grow at a CAGR of 25.60% from 2025 to 2032.
Global Artificial Blood Substitutes Market 2018-2032 USD Million
Global Artificial Blood Substitutes Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 12.25 USD Million
- Projected Market Size (2032): 76.05 USD Million
- CAGR (2025-2032): 25.60%
Key Findings of Global Artificial Blood Substitutes Market
- The Global Artificial Blood Substitutes Market was valued at 76.05 USD Million in 2024.
- The Global Artificial Blood Substitutes Market is likely to grow at a CAGR of 25.60% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Hemoglobin-Based Oxygen Carries (HBOCS) in Product Type Segment accounted for the largest share of the market with a revenue of 8.42 USD Million
- The fastest growing segment Injuries in Application Segment grew Fastest with a CAGR of 27.65% during the forecast period from 2024 to 2032.
Global Artificial Blood Substitutes Market Scope
- Neonatal Conditions
- Malignant Neoplasma
- Maternal Condition
- Organ Transplant
- Cardiovascular Diseases
- Injuries
- Synthetic Polymers
- Stem Cells
- Microorganism Based Recombinant Hb
- Human Blood
- Animal Blood
- Perfluorocarbon (PFCS)
- Hemoglobin-Based Oxygen Carries (HBOCS)
- Clinics
- Others
- Blood Banks
- Hospitals
Global Artificial Blood Substitutes Market Data Coverage Insights
Study Period | 2024-2032 |
Base Year | 2020 |
Unit | Revenue in USD Million |
Market Value in 2024 | 12.25 USD Million |
Market Value in 2032 | 76.05 USD Million |
CAGR (2025-2032) | 25.60% |
Historic Data | 2016-2023 |
Market Segments Covered | Application, Source, Product Type, End User |
Regional Insights:
-
Leading Market (2024-2032): Global, leading in terms of revenue 12.25 USD Million in 2024
- Key Country: U.S., leading in terms of revenue with value of 6.43 USD Million in 2024.
Segments and Scope
-
Global Artificial Blood Substitutes Market to 2032, By Application
- Injuries is the largest segment in Global Artificial Blood Substitutes Market to 2032 with a revenue of 3.38 USD Million in the year 2024.
- Injuries is the Fastest growing segment in Global Artificial Blood Substitutes Market to 2032 with a Growth rate of 27.65 % in forecast period 2025-2032.
-
Global Artificial Blood Substitutes Market to 2032, By Source
- Animal Blood is the largest segment in Global Artificial Blood Substitutes Market to 2032 with a revenue of 6.80 USD Million in the year 2024.
- Animal Blood is the Fastest growing segment in Global Artificial Blood Substitutes Market to 2032 with a Growth rate of 26.17 % in forecast period 2025-2032.
-
Global Artificial Blood Substitutes Market to 2032, By Product Type
- Hemoglobin-Based Oxygen Carries (HBOCS) is the largest segment in Global Artificial Blood Substitutes Market to 2032 with a revenue of 8.42 USD Million in the year 2024.
- Hemoglobin-Based Oxygen Carries (HBOCS) is the Fastest growing segment in Global Artificial Blood Substitutes Market to 2032 with a Growth rate of 25.93 % in forecast period 2025-2032.
-
Global Artificial Blood Substitutes Market to 2032, By End User
- Hospitals is the largest segment in Global Artificial Blood Substitutes Market to 2032 with a revenue of 6.67 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Global Artificial Blood Substitutes Market to 2032 with a Growth rate of 25.85 % in forecast period 2025-2032.
Global Artificial Blood Substitutes Market Company Share Analysis
Company Name |
![]() |
||
KaloCyte, Inc. | |||
VISUMED EQUIPMENTS | |||
Hemoglobin Oxygen Therapeutics LLc | |||
HEMARINA | |||
European Medicines Agency |

Global Artificial Blood Substitutes Market Geographical Sales Distribution, 2018-2032 USD Million

Global Artificial Blood Substitutes Market Company Profiling

Industry Related Reports
Frequently Asked Questions
Global Artificial Blood Substitutes Market Scope
- Neonatal Conditions
- Malignant Neoplasma
- Maternal Condition
- Organ Transplant
- Cardiovascular Diseases
- Injuries
- Synthetic Polymers
- Stem Cells
- Microorganism Based Recombinant Hb
- Human Blood
- Animal Blood
- Perfluorocarbon (PFCS)
- Hemoglobin-Based Oxygen Carries (HBOCS)
- Clinics
- Others
- Blood Banks
- Hospitals
Frequently Asked Questions
Global Artificial Blood Substitutes Market Company Profiling

Frequently Asked Questions
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.